Oncotarget

September 15, 2020

View Archive »

About The Cover

The cover for issue 37 of Oncotarget features Figure 7, "The combination of romidepsin and KU60019 is synergistic in a xenograft model of MCL," by Scotto, et al.

Table of Contents

Editorial

Small ceramide tames big p53 mutant beast

Small ceramide tames big p53 mutant beast

https://doi.org/10.18632/oncotarget.27738

Ronald A. Hill, Zhijun Liu,  and Yong-Yu Liu
3418-3419
PDF  |  How to cite

Research Papers

SNPs in the interleukin-12 signaling pathway are associated with breast cancer risk in Puerto Rican women

SNPs in the interleukin-12 signaling pathway are associated with breast cancer risk in Puerto Rican women

https://doi.org/10.18632/oncotarget.27707

Angel Núñez-Marrero, Nelly Arroyo, Lenin Godoy, Mohammad Zillur Rahman, Jaime L. Matta,  and Julie Dutil
3420-3431

ATM inhibition overcomes resistance to histone deacetylase inhibitor due to p21 induction and cell cycle arrest

ATM inhibition overcomes resistance to histone deacetylase inhibitor due to p21 induction and cell cycle arrest

https://doi.org/10.18632/oncotarget.27723

Luigi Scotto, Xavier J. Serrano, Kelly Zullo, Cristina Kinahan, Changchun Deng, Ahmed Sawas, Susan Bates,  and Owen A. O’Connor
3432-3442
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Podcast

Novel combination therapy for melanoma induces apoptosis via a gap junction positive feedback mechanism

Novel combination therapy for melanoma induces apoptosis via a gap junction positive feedback mechanism

https://doi.org/10.18632/oncotarget.27732

Archis Bagati, Timothy C. Hutcherson, Zethan Koch, Joseph Pechette, Hossein Dianat, Cory Higley, Lisa Chiu, Yesul Song, Jay Shah, Elana Chazen, Andrew Nicolais, Peter Casey, Kyle Thompson, Kevin Burke, Mikhail A. Nikiforov, Jennifer Zirnheld,  and Shoshanna N. Zucker
3443-3458
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

Biological evaluation of pyrazolyl-urea and dihydro-imidazo-pyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma

Biological evaluation of pyrazolyl-urea and dihydro-imidazo-pyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma

https://doi.org/10.18632/oncotarget.27733

Barbara Marengo, Elda Meta, Chiara Brullo, Chiara De Ciucis, Renata Colla, Andrea Speciale, Ombretta Garbarino, Olga Bruno,  and Cinzia Domenicotti
3459-3472
Abstract  |  PDF  |  Full Text  |  How to cite

Expression of Glioma-associated oncogene homolog 1 as biomarker with sonidegib in advanced basal cell carcinoma

Expression of Glioma-associated oncogene homolog 1 as biomarker with sonidegib in advanced basal cell carcinoma

https://doi.org/10.18632/oncotarget.27735

Reinhard Dummer, Li Liu, Nicholas Squittieri, Ralf Gutzmer,  and John Lear
3473-3483
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

Corrections

Correction: Improved anti-tumor efficacy via combination of oxaliplatin and fibrin glue in colorectal cancer

Correction: Improved anti-tumor efficacy via combination of oxaliplatin and fibrin glue in colorectal cancer

https://doi.org/10.18632/oncotarget.27605

Yuzhu Hu, Ting Yu, Xiaoxiao Liu, Yihong He, Lihong Deng, Jiajuan Guo, Yuanqi Hua, Ting Luo,  and Xiang Gao
3484-3485
Correction  |  PDF  |  How to cite


Copyright © 2024 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC